Magnesium sulfate Diasporal magnesium 2 mmol ampoules 50X5 ml

Protina Pharmazeutische GmbH

Sale price £149.95 Regular price £200.00

Tax included. Shipping calculated at checkout.

Magnesium sulfate Diasporal magnesium 2 mmol ampoules 50X5 ml

magnesium sulfate, Magnesium Diasporal 2 mmol ampoules



1 ampoule (5 ml) injection
solution contains the medicinally active ingredient: Magnesium sulfate x 7 H2O 793.0 mg Magnesium content: 2 mmol = 4 mval = 48.61 mg



Diasporal magnesium, magnesium sulfate Areas of application:


Proven magnesium deficiency if this is the cause of disorders muscle activity (neuromuscular disorders, calf cramps).
Further gynecological areas of application can be found in the instructions for use.

Active ingredient: magnesium sulfate-7-water

Against cramps and tension.

active ingredients

  • 493 mg magnesium sulfate-7 water

excipients

  • water for injections

What is Magnesium-Diasporal® 2 mmol and what is it used for?
Magnesium-Diasporal® 2 mmol is a mineral preparation.
Magnesium-Diasporal® 2 mmol is used for:
Magnesium deficiency:
If it is the cause of muscle activity disorders (neuromuscular disorders, calf cramps); Tetany can also be a sign of calcium deficiency. Calcium deficiency must therefore be ruled out by determining the serum calcium level before starting magnesium therapy. Therapy with magnesium sulfate is indicated only when the serum magnesium level is below normal (0.8 to 1.1 mmol/l) and the serum calcium level is normal (2.2 to 2.7 mmol/l). . In the event of a tendency to abortion, attempts to give birth prematurely, fetal hypertrophy if these are caused by a reduction in the magnesium-dependent enzyme activity of the placenta. Here, too, treatment with magnesium sulfate may only be carried out if the magnesium serum level falls below the normal values.

What do you have to consider before using Magnesium-Diasporal® 2 mmol?
Magnesium-Diasporal® 2 mmol must not be used:
in the case of pronounced bradycardia (slow heart activity), myasthenia gravis (muscle weakness) and AV block (interruption of the conduction system in the heart).
Particular caution is required when using Magnesium-Diasporal® 2 mmol
. Severe renal excretion disorders. A dose adjustment to the degree of the elimination disorder is necessary.
pregnancy and breast feeding period
There is no evidence of a risk of malformations when magnesium salts are administered during pregnancy. However, documented human experience with use in early pregnancy is limited. If magnesium salts are administered shortly before birth, the newborn should be monitored for signs of toxicity (neurological depression with respiratory depression, muscle weakness, loss of reflexes) during the first 24 to 48 hours of life. The administration of aminoglycoside antibiotics should be avoided during this period as there are indications of interactions.

What should be observed when mixing Magnesium-Diasporal® 2 mmol with other solutions?
Because of possible precipitation, Magnesium-Diasporal® 2 mmol should not be mixed with solutions containing calcium, phosphate, tetracycline or alcohol.

Interactions with other medicinal products
Diuretics, aminoglycoside antibiotics (such as gentamycin, tobramycin, amphotericin B), immunosuppressants (such as cyclosporin A), cytostatics (such as cisplatin) and digitalis glycosides cause increased excretion of magnesium through the kidneys.

The following drugs should not be given at the same time:

  • Curare-type muscle relaxants – these enhance the action of magnesium at the motor endplate.
  • Barbiturates, narcotics or other hypnotics - because of the risk of respiratory depression.
  • Calcium salts – these reduce the effects of magnesium.